Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma
European Journal of Clinical Pharmacology · 2025
DOI: 10.1007/s00228-024-03797-0 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Clinical Pharmacology, 2025. Verfasst von Xinrui Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacometrics, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, No.120…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Funds of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pharmacometrics, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, No.1200 Cailun Road, Shanghai, 201203, China.
- Center for Pharmacometrics, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, No.1200 Cailun Road, Shanghai, 201203, China. qingshan.zheng@drugchina.net.
- Center for Pharmacometrics, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, No.1200 Cailun Road, Shanghai, 201203, China. lujin.li@drugchina.net.
Förderung
- National Natural Science Funds of China
- National Key Research and Development Program of China
Zitieren
APA
Wang, X., Huang, J., Liu, Y., Wu, L., Cai, R., Zheng, Q., & Li, L. (2025). Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03797-0
Vancouver
Wang X, Huang J, Liu Y, Wu L, Cai R, Zheng Q, et al. Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma. European Journal of Clinical Pharmacology. 2025. doi:10.1007/s00228-024-03797-0
BibTeX
@article{Wang2025,
author = {Wang, Xinrui and Huang, Jihan and Liu, Yixiao and Wu, Lijuan and Cai, Ruifen and Zheng, Qingshan and Li, Lujin},
title = {Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma},
journal = {European Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1007/s00228-024-03797-0}
}
EUVIMED